Venture capital news covering startup funding, VC deals, funding rounds, investor activity, and the startup ecosystem.
Stad established the San Francisco-based Dragoneer Investment Group, a firm managing over $35 billion in assets. The company specializes in technology investments, holding stakes in major companies such as OpenAI, Anthropic, DoorDash, Spotify, and Airbnb.
Early Anthropic investor Anjney Midha criticized traditional venture capital firms for failing to capitalize on the artificial intelligence revolution. He defended his continued investment in Anthropic, predicting that public markets will soon embrace frontier AI technologies.
Dexmal is pursuing a roughly $3 billion valuation in its current funding round, confirming details at the World Robot Conference in Beijing. The company aims to showcase strong investor interest in physical artificial intelligence, building on previous backing from Alibaba and NIO Capital.
Cityblock Health has completed its acquisition of Homeward through an all-stock transaction. The deal provides an exit for Homeward, which had previously reduced its workforce earlier this year. Cityblock also secured $116 million in Series E funding from General Catalyst.
The article argues that Form Energy's recent down-round valuation reflects tighter private markets and investor preference for AI-focused startups rather than waning faith in the company's iron-air battery technology. It contends that strong fundamentals, political tailwinds, and expanding commercial applications remain intact despite the lower pre-money valuation.
The article argues that TechCrunch Disrupt 2026 offers investors a critical infrastructure for sourcing AI-era startups through curated networking and vetted pitches. It outlines specific strategies for different investment stages, emphasizing the event's role in accelerating deal flow and providing market intelligence ahead of competitors.
California-based MaxQ Medical secured $31.5 million in Series A funding led by Olympus Innovation Ventures, Atlantic Blue Ventures, and S3 Ventures. The company will use the capital to expand its team and advance clinical programs for its transurethral platform combining ultrasound imaging with tissue-selective therapy for benign prostate hyperplasia.
Andreessen Horowitz revealed that 44% of its recent app fund investments involve international founders, driven by increased enterprise willingness to pay for AI solutions abroad. The firm actively pursues global dealflow, spending over one million air miles annually rather than requiring US relocation.
The commentary argues that rapid AI advancements are drastically shortening the viability of venture capital investments made in 2024, rendering many previously promising startups obsolete by 2026. It suggests VCs must urgently reassess portfolios, distinguishing between insulated businesses with proprietary data and those exposed to disruption from major AI models.